Search

everythinglearnresearchcommunity

for

Search:↓

Human skin produces sex hormones like estrogen and testosterone, influenced by ARO and StAR, which may affect skin elasticity and hair growth.

The effects of estrogen on human hair growth are unclear and need more research.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Women generally handle heart enlargement better than men, but it's riskier for them if it occurs; hormones like estrogen offer some protection.

Oophorectomy lowers testosterone and estrogen levels in both premenopausal and postmenopausal women, with postmenopausal women still producing significant testosterone.

Melatonin helped some Pomeranian dogs regrow hair, but it wasn't linked to estrogen receptors.

Sex hormones like estrogen and testosterone may affect COVID-19 severity differently in men and women, potentially influencing prevention and treatment strategies.

Androgen excess disorders in women were effectively treated with spironolactone, estrogen, and dexamethasone.

Estrogen increases blood vessel growth factor production, while testosterone blocks this increase.

Sex hormones may affect COVID-19 severity, with estrogen possibly reducing risk and testosterone potentially increasing it.

Estrogen and prolactin may play bigger roles in female hair loss than previously thought.

Testosterone helps prevent skin damage in males by acting through both estrogen and androgen pathways.

Low estrogen compared to androgen may cause female hair loss.

A 17-year-old female with adrenogenital syndrome produces very high levels of androgens, which prevent complete feminization despite high estrogen doses.

Estrogen deficiency, like after menopause or certain surgeries, leads to faster skin aging and health issues.

Estrogen receptors may not affect mouse hair growth as previously thought, and oxybenzone in sunscreen is stable in sunlight.

Testosterone therapy can improve sexual satisfaction and mood in surgically menopausal women when used with estrogen, but its long-term safety and effects on naturally menopausal and premenopausal women are unclear.

Hormones during puberty increase certain receptors in the brain, and this change is influenced by estrogen levels.

Men born very underweight had higher estrogen levels but normal reproduction compared to normal birth weight men.

Transgender women on estrogen therapy can develop melasma and need proper skin care.

The effects of estrogen on human scalp hair growth are unclear and need more research.

Patients with advanced breast cancer and high hormone receptor levels who had surgery for ovarian/pelvic metastases lived longer, especially if they had high estrogen receptor levels.

The document concluded that more research is needed to understand how estrogen affects the enzyme involved in hirsutism development.

Long-term estrogen therapy in postmenopausal women can improve certain health markers, hair loss is common regardless of hormone use, stopping estrogen doesn't increase breast cancer risk, smoking does, and a balanced BMI is linked to lower mortality.

The paper suggests that a decrease in estrogen receptor activity may cause sexual dysfunction syndromes and proposes hormonal treatments.

Cancer rates are increasing in developed countries, with estrogen, aging, low vitamin D3, and HPV infection as common causes.

Testosterone therapy can help postmenopausal women with low sexual desire but needs more safety research and should be used with estrogen therapy.

A pregnant woman's skin condition improved after giving birth, possibly due to high estrogen levels during pregnancy.

Young women in West Bengal, India, with PCOS often have estrogen resistance, leptin receptor issues, folate deficiency, T2DM, and acanthosis, commonly linked to obesity.

Hormones like androgens, estrogen, thyroid hormones, and stress hormones can contribute to hair loss, and treatments target these hormonal imbalances.